Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Cancer-related molecular mechanisms research, and Cancer, Hypoxia, and Metabolism.
Enhanced Osteosarcoma Immunotherapy via CaCO<sub>3</sub> Nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for Photodynamic Therapy
Magnetically driven hydrogel microrobots for enhancing the therapeutic effect of anlotinib on osteosarcoma
Evaluation of thyroid-stimulating hormone-increased, hypertriglyceridemia and proteinuria as markers of anlotinib efficacy in advanced soft tissue sarcoma.
Efficacy of anlotinib in advanced soft tissue sarcoma by age, gender, and ECOG performance status.
Immunogenic cell death in cancer therapy: Present and emerging inducers
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis <i>via</i> dual blockade of VEGFR2 and MET in osteosarcoma
Efficacy and safety of anlotinib in advanced leiomyosarcoma: Subgroup analysis of a phase IIB trial (ALTER0203)
The effect of treatment line on the efficacy of anlotinib hydrochloride in advanced alveolar soft part sarcoma patients
Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.
Efficacy of anlotinib in advanced soft tissue sarcoma by prior lines of therapy, age and dose modification
Evaluation of hypertension and hand-foot syndrome as markers of anlotinib efficacy in advanced soft tissue sarcoma